Calendar
American Association of Cancer
Research Annual Meeting
April 16 – 20, 2016
New Orleans, LA
The AACR Annual Meeting will highlight the latest discoveries in every area of cancer research, from molecular
biology to clinical studies, epidemiology, prevention, and
survivorship.
International Society of Hematology’s
36th World Congress
April 18 – 21, 2016
Glasgow, Scotland, UK
The 36th World Congress, hosted by the British Society
of Hematology, gathers international members of the
hematology community to network and discuss the
changing clinical and laboratory practice landscape, as
well as report on advances in the field.
Oncology Nursing Society Annual Congress
April 28, 2016 – May 1, 2016
San Antonio, TX
This year’s Annual Congress will feature the latest
developments in oncology nursing and patient care,
as well as networking opportunities for the more than
3,000 attendees.
Highlights of ASH®
Get a synopsis of the top hematology research presented
at the 2015 ASH Annual Meeting and learn how it can help
improve your patient management and care strategies. This
is an opportunity to evaluate your diagnostic techniques
and therapeutic approaches and discuss with leading hematology experts and colleagues how new research and clinical
updates can be translated into patient care strategies.
There is one remaining meeting this year:
April 29 – 30, 2016
Porto Alegre, Brazil
*Please note the change in location from what was previously
published in past issues.
Live: 15”
® (brentuximab
® (brentuximab
ADCETRIS
ADCETRIS
vedotin)
vedotin)
forfor
injection,
injection,
forfor
intravenous
intravenous
use
use
Brief
Brief
Summary:
Summary:
seesee
package
package
insert
insert
forfor
complete
complete
prescribing
prescribing
information
information
WARNING:
WARNING:
PROGRESSIVE
PROGRESSIVE
MULTIFOCAL
MULTIFOCAL
LEUKOENCEPHALOPATHY
LEUKOENCEPHALOPATHY
(PML)
(PML)
JCJC
virus
virus
infection
infection
resulting
resulting
in in
PML
PML
and
and
death
death
can
can
occur
occur
in in
patients
patients
receiving
receiving
ADCETRIS.
ADCETRIS.
INDICATIONS
INDICATIONS
AND
AND
USAGE
USAGE
Classical
Classical
Hodgkin
Hodgkin
Lymphoma
Lymphoma
(HL)
(HL)
Post-auto-HSCT
Post-auto-HSCT
Consolidation
Consolidation
® (brentuximab
® (brentuximab
vedotin)
vedotin)
forfor
injection
injection
is is
a CD30-directed
a CD30-directed
antibody-drug
antibody-drug
conjugate
conjugate
indicated
indicated
forfor
ADCETRIS
ADCETRIS
thethe
treatment
treatment
of of
classical
classical
HLHL
at at
high
high
risk
risk
of of
relapse